Newsroom

November 06-10, 2024

SITC 2024

Meet ScaleReady in Houston alongside established leaders in the cancer immunotherapy field at this annual, information-filled conference. More information to come.

October 22-25, 2024

ESGCT Annual Congress 2024

The European Society of Gene and Cell Therapy has as its objective the promotion of science and research, join ScaleReady in 2024 in Rome at this exciting annual congress!

October 18-19, 2024

6th Annual TIL Therapies Summit

With 23+ TIL expert speakers, 75% of which new, 8 new companies and a brand-new Manufacturing & Characterization Bootcamp, this is an unrivalled opportunity to connect and collaborate with this niche community to secure clinical validation, turbocharge modified therapies and accelerate the next wave of TIL therapies into the clinic and beyond. Join us for our amazing presentation on October 23rd at 10am and at our booth!

October 07-09, 2024

Cell and Gene Meeting on the Mesa 2024

Save the dates for the upcoming conference October 7-9, 2024! We can’t wait to meet with you and the new venue in Phoenix! More information to come.

17 September 2024

9th Annual CAR-TCR Summit

Join ScaleReady at the 8th Annual CAR TCR Summit in Boston, MA for the industry’s trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers.

September 13-14, 2024

5th Annual ICLE Conference

Join us for the 5th International Conference on Lymphocyte Engineering –where the world's health innovators in immuno-gene therapy come together. More information coming soon!

10 September 2024

Advanced Therapies Europe 2024

Returning to Lisbon, Portugal, ScaleReady will be at the Advanced Therapies Europe 2024 Edition! Join our team to discuss the latest in cell and gene therapy manufacturing advances, and how the G-Rex bioreactor will simplify and streamline your processes ready for automation and scale. Make sure to join us for our in depth workshop discussion and our Plenary session hosted by the COO of CellReady, Ignacio Nunez. See you there!

September 04-06, 2024

ISCT 2024 Regional Meeting

Gothenburg Sweden is the setting for the annual ISCT Regional Meeting this coming September 4th - 6th. ScaleReady will be there, be sure to engage with our optimization specialists as we efficiently scale and effectively take your program from clinic to commercialization!

25 July 2024

5th Annual Gamma Delta T-Therapies Summit

Gamma Delta T-Therapies is back and so is ScaleReady. Pioneering important cell therapy manufacturing processes, join us at our booth in the Exhibit Hall as we collaborate at this important annual meeting, focused on an emerging, powerful T-Cell therapy development.

11 June 2024

6th Allogeneic Cell Therapies Summit

ScaleReady is the proud lead partner for the 6th Allogeneic Cell Therapies Summit in Boston this year! Make sure you join us for an in-depth presentation on Tuesday at June 11th at 10am to hear from the COO of CellReady, Ignacio Nunez. Ignacio will also be sitting on an insightful panel on Tuesday, June 11th at 3:40pm.

11 June 2024

3rd Process Development for Cell Therapies Summit

The ScaleReady booth will be live and active in Boston June 11-13 for the Annual Process Development Summit. It's more important than ever to employ quality by design and optimize processes for highly efficacious products that can easily transition from clinical trials to the market - and ScaleReady is poised to help CGT manufacturers. Make sure you join us for an amazing presentation from the COO of CellReady Ignacio Nunez at 11am on June 13th!

29 May 2024

ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing

The G-Rex® Grant Program will provide academic and commercial institutions engaged in IND enabling pre-clinical research, process development, and/or ongoing GMP manufacturing of cell and gene therapies with the material resources and services needed to implement or optimize a highly efficient G-Rex® based cell manufacturing platform.